SCHEIBLER LUKAS

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$119,571.90
Insider Sells Quantity
12
Insider Sells Sum
$5.71M

Insider Activity of SCHEIBLER LUKAS

According to the SEC Form 4 filings, SCHEIBLER LUKAS, being in a position of

  1. Chief Research Officer at Apellis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 10000 shares for $600,000,
    over all time since 2018-05-24, has bought 5870 shares for $119,572, and sold 113351 share for $5.71M.

The largest purchase of all time was on 2018-05-24 and amounted to 5870 shares of Apellis Pharmaceuticals, Inc. for $119,572.

The largest sale of all time was on 2022-04-01 and amounted to 22992 shares of Apellis Pharmaceuticals, Inc. for $1.27M.

Biography of SCHEIBLER LUKAS

No biography is available at this moment.

2023-12-01SaleApellis Pharmaceuticals, Inc.
APLS
Chief Research Officer
10,000
0.0084%
$60.00$600,000-21.69%
2023-09-06SaleApellis Pharmaceuticals, Inc.
APLS
Chief Research Officer
1,756
0.0015%
$43.01$75,526+12.12%
2022-05-27SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
10,000
0.0095%
$43.00$430,000+36.13%
2022-04-21SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
10,000
0.0079%
$43.00$430,000+3.91%
2022-04-05SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
1,218
0.0012%
$60.09$73,186-10.88%
2022-04-04SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
4,753
0.0044%
$57.18$271,788-9.55%
2022-04-01SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
22,992
0.0216%
$55.05$1.27M-4.05%
2022-02-11SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
3,332
0.0034%
$46.80$155,938+10.03%
2022-02-10SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
20,000
0.0216%
$50.00$1M+7.94%
2022-02-08SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
20,000
0.0202%
$45.00$900,000+12.09%
2022-01-31SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
2,466
0.0024%
$38.47$94,867+25.2%
2021-06-10SaleApellis Pharmaceuticals, Inc.
APLS
CHIEF INNOVATION OFFICER
6,834
0.0083%
$60.00$410,040-26.33%
2018-05-24PurchaseApellis Pharmaceuticals, Inc.
APLS
See Remarks
5,870
0.0108%
$20.37$119,572-10.08%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.